Caffeine consumption and the risk of primary open-angle glaucoma: A prospective cohort study

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 5, 2008, Pages 1924-1931

  Rang, Jae Hee ^a,d   Willett, Walter C ^a,b   Rosner, Bernard A ^a,b   Hankinson, Susan E ^a,b   Pasquale, Louis R ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ADULT; AGED; ARTICLE; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE EXAMINATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MEDICAL RECORD REVIEW; NORMAL HUMAN; OPEN ANGLE GLAUCOMA; PRIMARY GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; TEA; FEEDING BEHAVIOR; HEALTH CARE PERSONNEL; MIDDLE AGED; UNITED STATES;

ADULT; CAFFEINE; COFFEE; COHORT STUDIES; FOOD HABITS; GLAUCOMA, OPEN-ANGLE; HEALTH PERSONNEL; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TEA; UNITED STATES;

EID: 44649112694     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1425     Document Type: Article

References (46)

1. Quigley H. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC. Incident open-angle glaucoma and intraocular pressure. Ophthalmology. 2007;114:1810-1815.
3. Leske MC, Connell AMS, Wu S-Y, et al. Incidence of open-angle glaucoma: The Barbados Eye Studies. Arch Ophthalmol. 2001;119: 89-95.
4. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720; discussion 829-730.
5. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000; 130:429-440.
6. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
7. Peczon JD, Grant WM. Sedatives, stimulants, and intraocular pressure in glaucoma. Arch Ophthalmol. 1964;72:178-188.
8. Ricklefs G. Studies on the ways of life of glaucoma patients (in German). Doc Ophthalmol. 1968;25:43-99.
9. Ricklefs G, Pohls EU. Effect of caffeine containing tablets and Coca-Cola on the intraocular pressure of patients without glaucoma and patients with regulated glaucoma (in German). Rlin Monatsbl Augenheilkd. 1969;154:546 -551.
10. Ajayi OB, Ukwade MT. Caffeine and intraocular pressure in a Nigerian population. J Glaucoma. 2001;10:25-31.
11. Avisar R, Avisar E, Weinberger D. Effect of coffee consumption on intraocular pressure. Ann Pharmacother. 2002;36:992-995.
12. Higginbotham EJ, Kilimanjaro HA, Wilensky JT, Batenhorst RL, Hermann D. The effect of caffeine on intraocular pressure in glaucoma patients. Ophthalmology. 1989;96:624-626.
13. Okimi PH, Sportsman S, Pickard MR, Fritsche MB. Effects of caf- feinated coffee on intraocular pressure. Appl Nurs Res. 1991;4:72-76.
14. Massey LK. Caffeine and the elderly. Drugs Aging. 1998;13:43-50.
15. Barton J, Bain C, Hennekens CH, et al. Characteristics of respondents and non-respondents to a mailed questionnaire. Am J Public Health. 1980;70:823-825.
16. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. offee, caffeine, and cardiovascular disease in men. N Engl J Med. 1990;323:1026-1032.
17. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1114-1126.
18. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a emiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
19. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18:858 - 867.
20. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc. 1993;93:790-796.
21. Hu FB, Stampfer MJ, Rimm EB, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999;149:531-540.
22. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17-27.
23. Cox DR, Oakes D. The Analysis of Survival Data. London: Chapman and Hall; 1984.
24. DerSimonian R, Laird N. Meta-analyses in clinical trials. Control Clin Trials. 1986;7:177-188.
25. Armaly MF. Water-drinking test. I. Characteristics of the ocular pressure response and the effect of age. Arch Ophthalmol. 1970; 83:169-175.
26. de Leon J, Diaz FJ, Rogers T, et al. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27: 165-171.
27. Chandrasekaran S, Rochtchina E, Mitchell P. Effects of caffeine on intraocular pressure: the Blue Mountains Eye Study. J Glaucoma.2005;14: 504-507.
28. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology. 1989;96:1363-1368.
29. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. JAMA. 1991;266:369-374.
30. Duggal P, Klein AP, Lee KE, Klein R, Klein BE, Bailey-Wilson JE. Identification of novel genetic loci for intraocular pressure: a genomewide scan of the Beaver Dam Eye Study. Arch Ophthalmol. 2007;125:74-79.
31. Kurata K, Fujimoto H, Tsukuda R, Suzuki T, Ando T, Tokuriki M. Aqueous humor dynamics in beagle dogs with caffeine-induced ocular hypertension. J Vet Med Sci. 1998;60:737-739.
32. Opremcak EM, Weber PA. Interaction of timolol and caffeine on intraocular pressure. J Ocul Pharmacol. 1985;1:227-234.
33. Kurata K, Maeda M, Nishida E, et al. Relationship between caffeine- induced ocular hypertension and ultrastructure changes of non- pigmented ciliary epithelial cells in rats. J Toxicol Sci. 1997;22:447-454.
34. Shields MB. Chapter 2. Aqueous humor dynamics. I. Anatomy and physiology. Textbook of Glaucoma. Baltimore: Williams & Wilkins; 1998:5-31.
35. Suzuki R, Karageuzian LN, Crean EV, Anderson PJ. Effects of adrenergic agents and phosphodiesterase inhibitors on outflow facility and cell shape of bovine trabecular meshwork. Jpn J Oph- thalmol. 1997;41:31-37.
36. Adams BA, Brubaker RF. Caffeine has no clinically significant effect on aqueous humor flow in the normal human eye. Ophthalmology. 1990;97:1030-1031.
37. Okuno T, Sugiyama T, Tominaga M, Kojima S, Ikeda T. Effects of caffeine on microcirculation of the human ocular fundus. J pn J Ophthalmol. 2002;46:170-176.
38. Lotfi K, Grunwald JE. The effect of caffeine on the human macular circulation. Invest Ophthalmol Vis Sci. 1991;32:3028-3032.
39. Flammer J, Haefliger IO, Selim O, Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8:212-219.
40. Buckingham T, Young R. The rise and fall of intra-ocular pressure: the influence of physiological factors. Ophthalmic Physiol Opt. 1986;6:95-99.
41. Hodges LC, Kearse CE, Green K. Intraocular pressure-lowering activity of phenolic antioxidants in normotensive rabbits. Curr Eye Res. 1999;19:234-240.
42. Maher P, Hanneken A. Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest Ophthalmol Vis Sci. 2005;46:4796-4803.
43. Zhang B, Safa R, Rusciano D, Osborne NN. Epigallocatechin gal- late, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion. Brain Res. 2007.
44. Ascherio A, Zhang SM, Hernan MA, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol. 2001;50:56-63.
45. Hernandez-Avila M, Colditz GA, Stampfer MJ, Rosner B, Speizer FE, Willett WC. Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr. 1991;54:157-163.
46. Rothman KJ, Greenland S. Modern Epidemiology. Second ed. Philadelphia: Lippincott-Raven Publishers; 1998:130-131.